| FAPI-74 PET/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients FL Giesel, S Adeberg, M Syed, T Lindner, LD Jiménez-Franco, ... Journal of Nuclear Medicine 62 (2), 201-207, 2021 | 189 | 2021 |
| Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas—clinical results in 85 patients treated in a single institution leading to optimized … S Adeberg, C Hartmann, T Welzel, S Rieken, D Habermehl, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 859-864, 2012 | 164 | 2012 |
| Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study CG Rusthoven, M Yamamoto, D Bernhardt, DE Smith, D Gao, T Serizawa, ... JAMA oncology 6 (7), 1028-1037, 2020 | 158 | 2020 |
| Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors C Kratochwil, SE Combs, K Leotta, A Afshar-Oromieh, S Rieken, J Debus, ... Neuro-oncology 16 (3), 434-440, 2014 | 157 | 2014 |
| Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? SE Combs, S Rieken, W Wick, A Abdollahi, A von Deimling, J Debus, ... Radiation oncology 6, 1-5, 2011 | 156 | 2011 |
| Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated … SE Combs, S Adeberg, JO Dittmar, T Welzel, S Rieken, D Habermehl, ... Radiotherapy and Oncology 106 (2), 186-191, 2013 | 135 | 2013 |
| EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small … P Christopoulos, V Endris, F Bozorgmehr, M Elsayed, M Kirchner, J Ristau, ... International Journal of Cancer 142 (12), 2589-2598, 2018 | 115 | 2018 |
| Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer D Habermehl, K Kessel, T Welzel, H Hof, A Abdollahi, F Bergmann, ... Radiation oncology 7, 1-7, 2012 | 110 | 2012 |
| Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients SE Combs, M Ellerbrock, T Haberer, D Habermehl, A Hoess, O Jäkel, ... Acta Oncologica 49 (7), 1132-1140, 2010 | 106 | 2010 |
| Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with … SE Combs, M Kieser, S Rieken, D Habermehl, O Jäkel, T Haberer, ... BMC cancer 10, 1-9, 2010 | 101 | 2010 |
| Randomised phase I/II study to evaluate c arbon ion ra d ioth e rapy ve r sus fractionat ed stereotactic radiotherapy in patients with recurrent or progressive gl iom as: The … SE Combs, I Burkholder, L Edler, S Rieken, D Habermehl, O Jäkel, ... BMC cancer 10, 1-8, 2010 | 90 | 2010 |
| Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy S Rieken, D Habermehl, FL Giesel, C Hoffmann, U Burger, H Rief, ... Radiotherapy and Oncology 109 (3), 487-492, 2013 | 81 | 2013 |
| Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients S Regnery, S Adeberg, C Dreher, J Oberhollenzer, JE Meissner, ... Oncotarget 9 (47), 28772, 2018 | 75 | 2018 |
| Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07) D Beier, M Proescholdt, C Reinert, T Pietsch, DTW Jones, SM Pfister, ... Neuro-oncology 20 (3), 400-410, 2018 | 74 | 2018 |
| Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga … SE Combs, T Welzel, D Habermehl, S Rieken, JO Dittmar, K Kessel, ... Acta oncologica 52 (3), 514-520, 2013 | 74 | 2013 |
| Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma P Christopoulos, M Kirchner, F Bozorgmehr, V Endris, M Elsayed, ... International Journal of Cancer 144 (1), 190-199, 2019 | 73 | 2019 |
| Melanoma brain metastases–Interdisciplinary management recommendations 2020 R Gutzmer, D Vordermark, JC Hassel, D Krex, C Wendl, D Schadendorf, ... Cancer Treatment Reviews 89, 102083, 2020 | 71 | 2020 |
| Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma C Blattmann, S Oertel, D Schulz-Ertner, S Rieken, S Haufe, V Ewerbeck, ... BMC cancer 10, 1-7, 2010 | 71 | 2010 |
| Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects SB Harrabi, S Adeberg, T Welzel, S Rieken, D Habermehl, J Debus, ... Radiation Oncology 9, 1-7, 2014 | 68 | 2014 |
| Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study … S Rieken, D Habermehl, T Haberer, O Jaekel, J Debus, SE Combs Radiation Oncology 7, 1-7, 2012 | 67 | 2012 |
